Please login to the form below

Not currently logged in


This page shows the latest Rienso news and features for those working in and with pharma, biotech and healthcare.

Amag buys into maternal health business

Amag buys into maternal health business

Feraheme is sold outside the US by Takeda as Rienso and was approved in Europe in 2012.

Latest news

  • Death leads to recall of batch of Takeda's Rienso in Switzerland Death leads to recall of batch of Takeda's Rienso in Switzerland

    Both Amag and Takeda are now investigating the Swiss batch of Rienso, while the introduction of new batches will depend on approval by Swiss health regulator Swissmedic. ... Rienso is sold as Feraheme in the US and Canada, where Takeda is the exclusive

  • SMC approves Eliquis, restricts use of Rienso SMC approves Eliquis, restricts use of Rienso

    The Scottish Medicines Consortium (SMC) has accepted Eliquis, Pfizer and Bristol-Myers Squibb's anticoagulant, and backed the restricted use of Takeda's anaemia drug Rienso within NHS Scotland. ... it. “Acceptance of Rienso by the SMC marks an

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...